Abstract
Pulmonary carcinoids (PC) are rare malignant neuroendocrine tumors with indolent course. It is estimated that PC overall encompass 1% to 5% of all lung neoplasms. The surgical resection is the preferred treatment modality but the indolent nature of the disease makes interpretation of survival numbers problematic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
